类器官与球状体作为胆汁淤积性肝损伤和胆管癌研究模型
胆管病(如原发性硬化性胆管炎、胆道闭锁和胆管癌)实验模型有限;经典二维单层培养无法模拟细胞间相互作用,而三维类器官和球状体可模拟肝细胞间架构与通讯。本文综述了利用多能干细胞、肝祖细胞、肝活检原代细胞及永生化细胞系构建肝/胆类器官/球状体的方法,并指出其基因操作可行、功能特征适合药物筛选,可作为胆管病的体外模型。
要点
- 三维类器官/球状体能模拟肝细胞间相互作用,优于二维培养。
- 多种细胞来源可用于生成肝/胆类器官,包括多能干细胞和肝活检原代细胞。
- 类器官可进行基因操作并用于药物筛选,有潜力作为胆管病体外模型。
核心结论
- 三维肝细胞培养系统(类器官和球状体)有潜力作为胆汁淤积性肝损伤和胆管癌的体外研究模型。
研究设计与样本
- 综述,总结当前类器官/球状体形成方法及其作为胆管病体外模型的潜力。
主要发现
- 胆管病涉及胆管细胞、肝星状细胞和巨噬细胞等多种肝细胞协调反应,经典二维单层培养无法模拟细胞间相互作用。
- 三维类器官和球状体可模拟肝细胞间的细胞相互作用和架构。
- 已证明可利用多能干细胞、肝祖细胞、肝活检原代细胞和永生化细胞系等多种细胞来源生成肝或胆类器官/球状体。
- 类器官可进行转染和转导等基因操作,已建立的类器官具有适合药物筛选的功能特征。
临床怎么用
- 可将类器官/球状体作为胆管病(如原发性硬化性胆管炎、胆道闭锁和胆管癌)的体外模型用于研究。
- 可利用类器官进行基因操作和药物筛选。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cholangiopathies, such as primary sclerosing cholangitis, biliary atresia, and cholangiocarcinoma, have limited experimental models. Not only cholangiocytes but also other hepatic cells including hepatic stellate cells and macrophages are involved in the pathophysiology of cholangiopathies, and these hepatic cells orchestrate the coordinated response against diseased conditions. Classic two-dimensional monolayer cell cultures do not resemble intercellular cell-to-cell interaction and communication; however, three-dimensional cell culture systems, such as organoids and spheroids, can mimic cellular interaction and architecture between hepatic cells. Previous studies have demonstrated the generation of hepatic or biliary organoids/spheroids using various cell sources including pluripotent stem cells, hepatic progenitor cells, primary cells from liver biopsies, and immortalized cell lines. Gene manipulation, such as transfection and transduction can be performed in organoids, and established organoids have functional characteristics which can be suitable for drug screening. This review summarizes current methodologies for organoid/spheroid formation and a potential for three-dimensional hepatic cell cultures as in vitro models of cholangiopathies.
引用
- Sato K, Zhang W, Safarikia S, et al. Organoids and Spheroids as Models for Studying Cholestatic Liver Injury and Cholangiocarcinoma. Hepatology. 2021. PMID: 33222247. doi:10.1002/hep.31653
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。